• Home
  • Technology
    • Big Data
    • IT Services
    • Cyber Security
    • Cloud
    • IOT
    • Networking
    • ERP
    • Robotics
    • Biotechnology
  • Industry
    • Healthcare
    • Retail
    • Telecom
    • Marketing
    • Mining & Metals
    • Banking & Finance
    • Legal
    • Food & Beverage
    • Energy
  • Magazines
    • 10 Most Innovative Healthcare Leaders to Watch 2022
    • 10 Best Influential Leaders to Watch 2022
    • 10 Best Companies of the Year 2022
    • Top 5 AR/VR Solution Providers to Know in 2022
    • 10 Best Innovative Companies to watch In 2022
    • 10 Best Companies of the Year 2021
  • Clients Speak
  • Our Clients
  • Press Release
  • Privacy Policy
  • Terms & Conditions
Facebook Twitter Instagram LinkedIn
  • About Us
  • Contact Us
  • Terms & Conditions
  • Privacy Policy
Facebook Twitter Instagram LinkedIn
Corporate Leaders Magazine | International Business News Magazine | Entrepreneur Global Business Ideas Corporate Leaders Magazine | International Business News Magazine | Entrepreneur Global Business Ideas
  • Home
  • Technology
    • Big Data
    • IT Services
    • Storage
    • Cyber Security
    • Cloud
    • IOT
    • Networking
    • Robotics
    • ERP
    • Biotechnology
  • Industry
    • Healthcare
    • Retail
    • Telecom
    • Marketing
    • Mining & Metals
    • Banking & Finance
    • Legal
    • Food & Beverage
    • Energy
    • Startup
  • Magazines
    • 10 Most Innovative Healthcare Leaders to Watch in the World 2022
    • 10 Best Influential Leaders to Watch 2022
    • 10 Best Companies of the Year 2022
    • Top 5 AR/VR Solution Providers in 2022
    • 10 Best Innovative Companies to watch in 2022
    • 10 Best Companies of the Year 2021
  • Clients Speak
  • Our Clients
  • Featured Leaders
  • Press Release
Corporate Leaders Magazine | International Business News Magazine | Entrepreneur Global Business Ideas Corporate Leaders Magazine | International Business News Magazine | Entrepreneur Global Business Ideas
Home»Healthcare»FDA says yes to Covid-19 Vaccines for Young Children
Healthcare

FDA says yes to Covid-19 Vaccines for Young Children

FDA gives green signal for COVID-19 vaccines young children under the age of 5 years and as young as 6 months are going to get their Covid-19 Vaccine shots. FDA (US Food and Drug Administration) members collectively agreed on the decision that vaccines from Moderna Inc (MRNA.O) and Pfizer Inc (PFE.N)/BioNTech SE (22UAy.DE) can be used for even the youngest American children by answering yes to the question, “Based on the totality of scientific evidence available, do the benefits of the Moderna COVID-19 Vaccine when administered as a 2-dose series (25 micrograms each dose) outweigh its risks for use in infants and children 6 months through 5 years of age?” Moreover they replied in the affirmative to this as well-, “Based on the totality of scientific evidence available, do the benefits of the Pfizer-BioNTech COVID-19 Vaccine when administered as a 3-dose series (3 micrograms each dose) outweigh its risks for use in infants and children 6 months through 4 years of age?”

Why is Vaccines for Young Children is Necessary?

Vaccines for Young Children is indeed necessary. Though the disease is less effective in  children, FDA official Peter Marks to the panel said, “I think we have to be careful that we don’t become numb to the number of pediatric deaths because of the overwhelming number of older deaths,” Reingold, of the University of California, Berkeley said, “If we have a vaccine with benefits that outweigh the risks, then making it available to people is a reasonable choice,”

Expert’s suggestion

Speaking of the necessity of vaccines for young children, an associate professor of microbiology and immunology at the University of Michigan Medical School Oveta Fuller about Moderna vaccine, “The benefits seem to clearly outweigh the risks, particularly for those with young children who may be in kindergarten or in collective child care,”

Symptoms seen after shots

Dr. Rituparna Das, Moderna’s vice president of Covid-19 vaccines clinical development said, “Pain was the most common event,” She added, “Young children’s events included fever, headache, fatigue, myalgia, arthralgia, nausea, vomiting and chills. For infants and toddlers, events included fever, irritability, crying, sleepiness and loss of appetite.”

Related Posts

After Covid-19, FLU is the new primary respiratory illness in USA

December 26, 2022

Pfizer Inc. and BioNTech signed a $3.2 billion deal with the U.S. government

July 5, 2022

Healthcare Technology shaping the medical field of the future

March 1, 2022

The Network Tech Needed to Support Patient Care from Anywhere

October 18, 2021

Leave A Reply Cancel Reply

Stay In Touch
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
Recent

Lanrex: Helping Businesses Grow With Digital Transformation

August 28, 2022

MYLÉ: Combining Modern Design And Technology To Offer a Premium Vaping Experience

August 28, 2022

Maisonette: Nurturing Parenting and Upgrading kids’ Lifestyle

November 10, 2022

You-VR: An Avid Player in VR Solution Provider

April 2, 2022

EPI Group: A Leading Geoscience and Geophysical Consultancy

December 18, 2022

Subscribe to Updates

Get the latest creative news from SmartMag about art & design.

About Us

Corporate Leaders Magazine is one of the acclaimed monthly/quarterly business magazines in the country. We aim to cater to Business Owners and Entrepreneurship Enthusiasts of the country with disruptive entrepreneurship stories.

Facebook Twitter Instagram LinkedIn
Topics
  • Big Data
  • Cloud
  • IOT
  • Telecom
  • Tech News
Contact Info

5214F Diamond Hts Blvd Unit #1056, San Francisco, CA 94131, USA

Phone: +1(760)-284-3025

Email Us: info@corporateleadersmagazine.com

Latest Issue
dbf5675a-76a2-4eca-b687-4e19e37b64f2
Cover Featured (1) (1)
10 Best Companies of the Year 2022
b31b8176-d515-47b9-b2d2-c404b6d57e7f
5748f23d-3749-4574-a231-640e9d53100f
7058d2aa-6f76-4472-8cba-69e2a6a85c0d
10 Best Companies of the Year 2022
b31b8176-d515-47b9-b2d2-c404b6d57e7f
5748f23d-3749-4574-a231-640e9d53100f
7058d2aa-6f76-4472-8cba-69e2a6a85c0d
Copyright © 2023 Corporate Leaders Magazine LLC | All Rights Reserved